[
  {
    "ts": null,
    "headline": "RBC Capital Lifts HCA Healthcare, Inc. (HCA) Price Target Following Robust Revenue and Earnings Growth",
    "summary": "HCA Healthcare Inc. (NYSE:HCA) is one of the best blue-chip stocks to buy now. On October 27, analysts at RBC Capital reiterated an Outperform rating on HCA Healthcare Inc. (NYSE:HCA) and raised the price target to $482 from $449. The price target was raised following the company’s strong third‑quarter results, reported on October 24, which […]",
    "url": "https://finnhub.io/api/news?id=319f3ed267f7fe2775941cccbbdf1da73242528d8e0ba18f8914ab541a4a2e18",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763182252,
      "headline": "RBC Capital Lifts HCA Healthcare, Inc. (HCA) Price Target Following Robust Revenue and Earnings Growth",
      "id": 137486797,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HCA",
      "source": "Yahoo",
      "summary": "HCA Healthcare Inc. (NYSE:HCA) is one of the best blue-chip stocks to buy now. On October 27, analysts at RBC Capital reiterated an Outperform rating on HCA Healthcare Inc. (NYSE:HCA) and raised the price target to $482 from $449. The price target was raised following the company’s strong third‑quarter results, reported on October 24, which […]",
      "url": "https://finnhub.io/api/news?id=319f3ed267f7fe2775941cccbbdf1da73242528d8e0ba18f8914ab541a4a2e18"
    }
  }
]